NO306931B1 - Farmasoeytisk formulering av ACE-inhibitor og diuretisk middel - Google Patents

Farmasoeytisk formulering av ACE-inhibitor og diuretisk middel

Info

Publication number
NO306931B1
NO306931B1 NO943353A NO943353A NO306931B1 NO 306931 B1 NO306931 B1 NO 306931B1 NO 943353 A NO943353 A NO 943353A NO 943353 A NO943353 A NO 943353A NO 306931 B1 NO306931 B1 NO 306931B1
Authority
NO
Norway
Prior art keywords
diuretic
pharmaceutical formulation
ace inhibitor
ace
inhibitor
Prior art date
Application number
NO943353A
Other languages
English (en)
Norwegian (no)
Other versions
NO943353D0 (no
NO943353L (no
Inventor
J Krister Kristianson
Per Wold-Olsen
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of NO943353D0 publication Critical patent/NO943353D0/no
Publication of NO943353L publication Critical patent/NO943353L/no
Publication of NO306931B1 publication Critical patent/NO306931B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cardiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO943353A 1992-03-11 1994-09-09 Farmasoeytisk formulering av ACE-inhibitor og diuretisk middel NO306931B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84955492A 1992-03-11 1992-03-11
PCT/US1993/001813 WO1993017685A1 (fr) 1992-03-11 1993-03-02 Combinaisons d'inhibiteurs de l'enzyme de conversion de l'angiotensine et de diuretiques

Publications (3)

Publication Number Publication Date
NO943353D0 NO943353D0 (no) 1994-09-09
NO943353L NO943353L (no) 1994-09-09
NO306931B1 true NO306931B1 (no) 2000-01-17

Family

ID=25305985

Family Applications (1)

Application Number Title Priority Date Filing Date
NO943353A NO306931B1 (no) 1992-03-11 1994-09-09 Farmasoeytisk formulering av ACE-inhibitor og diuretisk middel

Country Status (11)

Country Link
US (1) US5686451A (fr)
EP (1) EP0643580A4 (fr)
JP (1) JPH07504659A (fr)
AU (1) AU686097B2 (fr)
CA (1) CA2130577C (fr)
DK (1) DK9200258U4 (fr)
ES (1) ES2083931T1 (fr)
NO (1) NO306931B1 (fr)
NZ (1) NZ249773A (fr)
WO (1) WO1993017685A1 (fr)
ZA (1) ZA931714B (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5721263A (en) * 1993-06-07 1998-02-24 Takeda Chemical Industries, Ltd. Pharmaceutical composition for angiotensin II-mediated diseases
GB9515826D0 (en) * 1995-08-02 1995-10-04 Oxford Health Management Ltd Treatment of nocturnal polyuria and medicaments therefor
GB2318057B (en) * 1995-08-02 1999-09-22 Oxford Health Management Ltd Treatment of nocturnal polyuria and medicaments therefor
SE9600120D0 (sv) * 1996-01-15 1996-01-15 Astra Ab Novel medical use
FR2771010B1 (fr) * 1997-11-19 2003-08-15 Adir Utilisation d'une combinaison d'un inhibiteur de l'enzyme de conversion de l'angiotensine et d'un diuretique pour le traitement des desordres microcirculatoires
GB2361185A (en) * 2000-04-10 2001-10-17 Nicholas J Wald Pharmaceutical formulation for the prevention of cardiovascular disease
WO2001080895A2 (fr) * 2000-04-26 2001-11-01 First Horizon Pharmaceutical Corporation Procedes et compositions pour le traitement de troubles cardiaques
US7226474B2 (en) 2000-05-01 2007-06-05 Endovascular Technologies, Inc. Modular graft component junctions
US7666221B2 (en) * 2000-05-01 2010-02-23 Endovascular Technologies, Inc. Lock modular graft component junctions
EP1317258B1 (fr) * 2000-06-28 2009-02-11 Merck & Co., Inc. Utilisation du allopurinol dans le traitement de l'hypertension
WO2003013434A2 (fr) * 2001-08-06 2003-02-20 Genomed, Llc Methodes et compositions destinees au traitement de maladies associees a des taux excessifs d'ace
US20050203169A1 (en) * 2001-08-06 2005-09-15 Moskowitz David W. Methods and compositions for treating diseases associated with excesses in ACE
WO2003071929A2 (fr) * 2002-02-26 2003-09-04 Endovascular Technologies, Inc. Dispositif de greffe vasculaire
US7708771B2 (en) * 2002-02-26 2010-05-04 Endovascular Technologies, Inc. Endovascular graft device and methods for attaching components thereof
US7942924B1 (en) 2002-03-04 2011-05-17 Endovascular Technologies, Inc. Staged endovascular graft delivery system
ES2322854T3 (es) * 2003-06-26 2009-06-30 Teva Pharmaceutical Industries Limited Composiciones farmaceuticas estables de derivados del acido 2-aza-biciclo(3.3.0)-octano-3-carboxilico.
EP1734931A2 (fr) * 2004-03-24 2006-12-27 Actavis Group Formulations de ramipril
GB0518129D0 (en) * 2005-09-06 2005-10-12 Arrow Int Ltd Ramipril formulation
US20070098782A1 (en) * 2005-10-28 2007-05-03 Selamine Limited Ramipril Formulation
GB2431579A (en) * 2005-10-28 2007-05-02 Arrow Int Ltd Ramipril formulations
JP2009533461A (ja) * 2006-04-19 2009-09-17 テバ ファーマシューティカル インダストリーズ リミティド ２−アザ−ビシクロ［３．３．０］−オクタン−３−カルボン酸誘導体の安定な医薬組成物
CN101478983A (zh) * 2006-07-10 2009-07-08 特瓦制药工业有限公司 含有对水分敏感的药物和第二药物的组合的稳定制剂及其制造方法
GB0624084D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril amino acid salts
GB0624087D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril combination salt
RU2618471C2 (ru) * 2012-12-03 2017-05-03 Закрытое Акционерное Общество "Вертекс" Пероральная фармацевтическая композиция диуретика и ингибитора АПФ в микронизированной форме, лекарственное средство и его применение

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1120400A (fr) * 1977-12-27 1982-03-23 Zola P. Horovitz Traitement de l'hypertension et medicaments utilises a cette fin
US5256687A (en) * 1985-09-09 1993-10-26 Hoechst Aktiengesellschaft Pharmaceutical composition for the treatment of high blood pressure
DE3532036A1 (de) * 1985-09-09 1987-03-26 Hoechst Ag Pharmazeutische zubereitung zur behandlung des bluthochdrucks
SE506179C2 (sv) * 1989-01-23 1997-11-17 Ciba Geigy Ag Farmaceutisk lågkomposition av benazepril och ett tiaziddiuretikum
ES2074769T3 (es) * 1991-07-01 1995-09-16 Gergely Gerhard Procedimiento para la elaboracion de un preparado farmaceutico con, al menos, dos principios activos diferentes y uso de un preparado de este tipo.

Also Published As

Publication number Publication date
AU686097B2 (en) 1998-02-05
NO943353D0 (no) 1994-09-09
DK9200258U4 (da) 1993-07-23
NO943353L (no) 1994-09-09
WO1993017685A1 (fr) 1993-09-16
ES2083931T1 (es) 1996-05-01
EP0643580A1 (fr) 1995-03-22
AU3736093A (en) 1993-10-05
ZA931714B (en) 1993-09-30
US5686451A (en) 1997-11-11
CA2130577C (fr) 2003-09-16
NZ249773A (en) 1996-01-26
JPH07504659A (ja) 1995-05-25
EP0643580A4 (en) 1995-04-19
CA2130577A1 (fr) 1993-09-16

Similar Documents

Publication Publication Date Title
NO306931B1 (no) Farmasoeytisk formulering av ACE-inhibitor og diuretisk middel
BR1100824A (pt) Composto e composição farmacêutica
IL102982A0 (en) Inhibitors of hiv reverse transcriptase and pharmaceutical compositions containing them
GB9314787D0 (en) Substituted carbamoyl and oxcarbonyl derivatives of biphenylmethylamines
AU5748194A (en) Mannitol derivatives and their use as inhibitors of aspartyl protease
FI954718A (fi) Heterosykliset johdannaiset iskeemian ja vastaavien sairauksien hoitamiseksi
KR950704251A (ko) 프롤릴 엔도펩티다아제 억제 활성을 갖는 화합물 및 그 약학적 용도(compound with prolyl endopeptdase inhibitor activity and pharmaceutical use thereof)
HUP9702241A3 (en) Use of 2-aminoindan derivatives and pharmaceutical compositions containing them
NO964758D0 (no) Anvendelse av von Willebrand-faktor og farmasöytiske preparater
NO924528L (no) Derivater av humant gallesalt-stimulert lipase og farmasoeytiske sammensetninger som inneholder disse
ATA147691A (de) Pharmazeutische zubereitungen mit einem gehalt an ace-inhibitor und dessen stabilisierung
NO20021832D0 (no) Farmasöytiske sammensetninger av tizoksanid og nitazoksanid
NO943428D0 (no) Terapeutisk aktive cyklobutendionderivater av indolylalkylpyridinyl- og pyrimidinylpiperaziner
GB9317103D0 (en) Derivatives of virginiamycin m1
NZ229816A (en) Imidazolylalkyl-substituted annelated indoloketone derivatives and pharmaceutical compositions
EE9600044A (et) Püranooni derivaadid kui proteaasi inhibiitorid ja viirusevastased toimeained
DE69333009T2 (de) Transdermale verabreichung von ketorolac
DK469087D0 (da) Farmaceutisk praeparat indeholdende et calciumoptagelsesblokerende middel og en ace-inhibitor.
FI950029A (fi) Uusia analgeettisia ja nootrooppisia lääkeaineita
DE4493151T1 (de) Pyrimidinderivate und Arzneimittel
FI945488A0 (fi) Tetrahydro- ja perhydroisokinoliinijohdannaiset ja niitä sisältävät terapeuttiset aineet
IL92419A0 (en) Derivatives of benzoxazimes and pharmaceutical compositions containing them
IL106767A0 (en) 2-deoxy-2-amino-hexuronyl derivatives of heparin and pharmaceutical compositions containing them
GB9415873D0 (en) Compounds that are inhibitors of acyl enzyme-a-cholesterol-o-acyl-transferase and have therapeutic activity, their use and pharmaceutical compositions contain
SE9300725D0 (sv) New use of composition for administration of drugs and method for administration of drugs

Legal Events

Date Code Title Description
MK1K Patent expired